Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer's Disease Treated with Anti-Amyloid Beta TherapyJerome Barakos, Everard G.B. Vijverberg, Carmen Castrillo‐Viguera et al.|The Journal of Prevention of Alzheimer s Disease|2022Cited by 154
Considerations for the real‐world management of ARIA from the aducanumab phase 3 studies EMERGE and ENGAGEPatrick Burkett, Samantha Budd Haeberlein, Spyros Chalkias et al.|Alzheimer s & Dementia|2021Cited by 1
Considerations for the Real-World Management of ARIA From the Aducanumab Phase 3 Studies EMERGE and ENGAGE (P1-1.Virtual)Richard E. Hughes, Samantha Budd Haeberlein, Karen Smirnakis et al.|Neurology|2022Cited by 0